MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)
מצבים רפואיים
Polycythemia Vera · ET (Essential Thrombocythemia) · Polycythemia Vera (PV) · Essential Thrombocythemia (ET) · Primary Myelofibrosis (MF) · Primary Myelofibrosis (PMF) · Myelofibrosis · Myelofibrosis (MF) · Myelofibrosis, Primary · Myelofibrosis, Post ET · Myelofibrosis, Post PV · Myelofibrosis (PMF) · Myelofibrosis,MF · Myelofibrosis; Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis · Myelofibrosis Due to and Following Polycythemia Vera · Myelofibrosis Transformation in Essential Thrombocythemia · Myelofibrosis With High Molecular Risk Mutations · MF · Secondary Myelofibrosis · Secondary Myelofibrosis in Myeloproliferative Disease · Secondary Myelofibrosis (Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis) · Post-Polycythemia Vera Myelofibrosis · Post-polycythemia Vera Myelofibrosis (PPV-MF) · Post-polycythemia Vera Myelofibrosis (Post-PV MF) · Post-polycythemia Vera Myelofibrosis(Post-PV MF) · Post-PV MF · Post-Essential Thrombocythemia Myelofibrosis · Post-essential Thrombocythemia Myelofibrosis (PET-MF) · Post-essential Thrombocythemia Myelofibrosis(Post-ET MF) · Post-essential Thrombocythemia Myelofibrosis (Post-ET MF) · Post-ET MF · Pre-fibrotic Myelofibrosis · Myeloproliferative Disorder · Myeloproliferative Disorders · Myeloproliferative Disorders (MPD) · Myeloproliferative Neoplasms (MPNs) · Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis · Myeloproliferative Neoplasm With 10% Blasts or Higher · Myeloproliferative Neoplasms · MPN · MPN (Myeloproliferative Neoplasms) · MPN-associated Myelofibrosis · Myeloproliferative Neoplasm, Unclassifiable · Myeloproliferative Neoplasm, Not Otherwise Specified · Accelerated Phase MPN · Accelerated Phase Myeloproliferative Neoplasm · Blast Phase MPN · Blast Phase Myeloproliferative Neoplasm · Thrombocythemia Myelofibrosis (PET-MF) · Thrombocythemia, Essential · Thrombocythemia, Hemorrhagic · Agnogenic Myeloid Metaplasia · Chronic Idiopathic Myelofibrosis · Idiopathic Myelofibrosis · MDS/MPN Crossover Syndromes
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
MPN Research Foundation, Chicago, Illinois, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact: Principal Investigator (Raajit Rampal, MD, PhD)
מובילי המחקר
Raajit Rampal, MD, PhD
Principal Investigator
Memorial Sloan Kettering Cancer Center